全文获取类型
收费全文 | 1835篇 |
免费 | 278篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 40篇 |
妇产科学 | 46篇 |
基础医学 | 292篇 |
口腔科学 | 35篇 |
临床医学 | 276篇 |
内科学 | 260篇 |
皮肤病学 | 34篇 |
神经病学 | 103篇 |
特种医学 | 84篇 |
外科学 | 280篇 |
综合类 | 43篇 |
一般理论 | 1篇 |
预防医学 | 264篇 |
眼科学 | 9篇 |
药学 | 179篇 |
中国医学 | 1篇 |
肿瘤学 | 170篇 |
出版年
2021年 | 27篇 |
2020年 | 31篇 |
2019年 | 25篇 |
2018年 | 42篇 |
2017年 | 24篇 |
2016年 | 34篇 |
2015年 | 27篇 |
2014年 | 56篇 |
2013年 | 43篇 |
2012年 | 91篇 |
2011年 | 80篇 |
2010年 | 46篇 |
2009年 | 33篇 |
2008年 | 62篇 |
2007年 | 88篇 |
2006年 | 79篇 |
2005年 | 74篇 |
2004年 | 79篇 |
2003年 | 60篇 |
2002年 | 71篇 |
2001年 | 52篇 |
2000年 | 64篇 |
1999年 | 57篇 |
1998年 | 21篇 |
1997年 | 21篇 |
1996年 | 20篇 |
1992年 | 32篇 |
1991年 | 44篇 |
1990年 | 36篇 |
1989年 | 46篇 |
1988年 | 59篇 |
1987年 | 42篇 |
1986年 | 34篇 |
1985年 | 39篇 |
1984年 | 32篇 |
1983年 | 30篇 |
1982年 | 19篇 |
1981年 | 18篇 |
1980年 | 16篇 |
1979年 | 36篇 |
1978年 | 25篇 |
1977年 | 18篇 |
1976年 | 21篇 |
1975年 | 25篇 |
1974年 | 19篇 |
1973年 | 17篇 |
1972年 | 24篇 |
1970年 | 21篇 |
1969年 | 15篇 |
1967年 | 16篇 |
排序方式: 共有2120条查询结果,搜索用时 15 毫秒
71.
Corey Heitz Justin Morgenstern Christopher Bond William K. Milne 《Academic emergency medicine》2019,26(2):246-249
This is a validation of a preplanned secondary analysis of the NEXUS II Head computed tomography (CT) decision instrument, focusing on the pediatric population. A total of 1,018 patients less than 18 years old, who underwent head CT imaging for blunt head trauma, were included. The decision instrument correctly identified all patient (27/27) who required neurosurgical intervention and 48 of 49 patients who had clinically significant head injury on CT imaging. 相似文献
72.
Christopher Bond Justin Morgenstern Corey Heitz William K. Milne 《Academic emergency medicine》2019,26(4):447-450
Adverse drug events (ADEs) are a significant cause of emergency department (ED) visits in North America and are frequently misdiagnosed. Despite evidence supporting improved health care outcomes for ED patients who have a pharmacist‐led medication review, EDs do not have sufficient clinical pharmacists to perform medication reviews on all patients. The study reviewed in this article aimed to validate clinical decision rules for use by clinical pharmacists and physicians to prioritize ED patients with ADEs. 相似文献
73.
Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groups 总被引:3,自引:1,他引:3 下载免费PDF全文
Kluin-Nelemans HC Buck G le Cessie S Richards S Beverloo HB Falkenburg JH Littlewood T Muus P Bareford D van der Lelie H Green AR Roozendaal KJ Milne AE Chapman CS Shepherd P;MRC HOVON groups 《Blood》2004,103(12):4408-4415
The optimal dose of interferon-alfa (IFN) for chronic myeloid leukemia (CML) is unknown. Retrospective analyses suggest that low doses are as effective as high doses, with less toxicity and fewer patients abandoning the drug. The Dutch Hemato-Oncology Association (HOVON) and British Medical Research Council (MRC) cooperative groups jointly performed randomized trials in newly diagnosed CML patients, comparing high-dose IFN (5 MIU/m(2) daily) with low-dose (3 MIU, 5 times a week). Both arms allowed additional hydroxyurea to keep the white blood cell count lower than 5 x 10(9)/L. Quality of life data were collected in a subset of patients. Between 1993 and 2001, 407 patients were randomized. At a median follow-up of 53 months, there were no significant differences in overall survival (odds ratio = 1.09, 95% confidence interval, 0.81-1.46), progression-free survival, and complete hematologic or major cytogenetic responses. Fewer patients in the low-dose group abandoned IFN for reasons other than transplant or progressive disease (P =.002, 58% vs 72% at 5 years). Quality of life data showed comparable results in both arms for most factors. There is no evidence of benefit for high-dose IFN compared with low-dose for the treatment of CML. Therefore, when IFN is combined with other drugs, low-dose IFN is advised, to minimize toxicity and costs. 相似文献
74.
Ferdinando Giacco Xueliang Du Vivette D. D’Agati Ross Milne Guangzhi Sui Michele Geoffrion Michael Brownlee 《Diabetes》2014,63(1):291-299
Differences in susceptibility to diabetic nephropathy (DN) between mouse strains with identical levels of hyperglycemia correlate with renal levels of oxidative stress, shown previously to play a central role in the pathogenesis of DN. Susceptibility to DN appears to be genetically determined, but the critical genes have not yet been identified. Overexpression of the enzyme glyoxalase 1 (Glo1), which prevents posttranslational modification of proteins by the glycolysis-derived α-oxoaldehyde, methylglyoxal (MG), prevents hyperglycemia-induced oxidative stress in cultured cells and model organisms. In this study, we show that in nondiabetic mice, knockdown of Glo1 increases to diabetic levels both MG modification of glomerular proteins and oxidative stress, causing alterations in kidney morphology indistinguishable from those caused by diabetes. We also show that in diabetic mice, Glo1 overexpression completely prevents diabetes-induced increases in MG modification of glomerular proteins, increased oxidative stress, and the development of diabetic kidney pathology, despite unchanged levels of diabetic hyperglycemia. Together, these data indicate that Glo1 activity regulates the sensitivity of the kidney to hyperglycemic-induced renal pathology and that alterations in the rate of MG detoxification are sufficient to determine the glycemic set point at which DN occurs. 相似文献
75.
76.
Corey Heitz Justin Morgenstern Christopher Bond William K. Milne 《Academic emergency medicine》2020,27(1):64-65
The Office of the Inspector General has the authority to levy fines relating to violations of the Emergency Medicine Treatment and Labor Act (EMTALA) for both medical and psychiatric care. Terp et al. have described the incidence of violations and penalties levied for psychiatric cases and compared them to that for medical. This article reviews that article and the podcast recorded with Dr. Terp and the ensuing discussion in the podcast and online. 相似文献
77.
78.
S. Ghazaleh Dashti Julie A. Simpson Amalia Karahalios Vivian Viallon Margarita Moreno-Betancur Lyle C. Gurrin Robert J. MacInnis Brigid M. Lynch Laura Baglietto Howard A. Morris Marc J. Gunter Pietro Ferrari Roger L. Milne Graham G. Giles Dallas R. English 《International journal of cancer. Journal international du cancer》2020,146(6):1541-1552
Adiposity increases estrogen receptor (ER)-positive postmenopausal breast cancer risk. While mechanisms underlying this relationship are uncertain, dysregulated sex-steroid hormone production and insulin signaling are likely pathways. Our aim was to quantify mediating effects of fasting insulin and free estradiol in the adiposity and ER-positive postmenopausal breast cancer association. We used data from a case–cohort study of sex hormones and insulin signaling nested within the Melbourne Collaborative Cohort Study. Eligible women, at baseline, were not diagnosed with cancer, were postmenopausal, did not use hormone therapy and had no history of diabetes or diabetes medication use. Women with ER-negative disease or breast cancer diagnosis within the first follow-up year were excluded. We analyzed the study as a cumulative sampling case–control study with 149 cases and 1,029 controls. Missing values for insulin and free estradiol were multiply imputed with chained equations. Interventional direct (IDE) and indirect (IIE) effects were estimated using regression-based multiple-mediator approach. For women with body mass index (BMI) >30 kg/m2 compared to women with BMI 18.5–25 kg/m2, the risk ratio (RR) of breast cancer was 1.75 (95% confidence interval [CI] 1.05–2.91). The estimated IDE (RR) not through the mediators was 1.03 (95% CI 0.43–2.48). Percentage mediated effect through free estradiol was 72% (IIE-RR 1.56; 95% CI 1.11–2.19). There was no evidence for an indirect effect through insulin (IIE-RR 1.12; 95% CI 0.68–1.84; 28% mediated). Our results suggest that circulating free estradiol plays an important mediating role in the adiposity–breast cancer relationship but does not explain all of the association. 相似文献
79.
Tuong L. Nguyen Shuai Li Gillian S. Dite Ye K. Aung Christopher F. Evans Ho N. Trinh Laura Baglietto Jennifer Stone Yun-Mi Song Joohon Sung Dallas R. English Mark A. Jenkins Pierre-Antoine Dugué Roger L. Milne Melissa C. Southey Graham G. Giles Malcolm C. Pike John L. Hopper 《International journal of cancer. Journal international du cancer》2020,147(2):375-382
Interval breast cancers (those diagnosed between recommended mammography screens) generally have poorer outcomes and are more common among women with dense breasts. We aimed to develop a risk model for interval breast cancer. We conducted a nested case–control study within the Melbourne Collaborative Cohort Study involving 168 interval breast cancer patients and 498 matched control subjects. We measured breast density using the CUMULUS software. We recorded first-degree family history by questionnaire, measured body mass index (BMI) and calculated age-adjusted breast tissue aging, a novel measure of exposure to estrogen and progesterone based on the Pike model. We fitted conditional logistic regression to estimate odds ratio (OR) or odds ratio per adjusted standard deviation (OPERA) and calculated the area under the receiver operating characteristic curve (AUC). The stronger risk associations were for unadjusted percent breast density (OPERA = 1.99; AUC = 0.66), more so after adjusting for age and BMI (OPERA = 2.26; AUC = 0.70), and for family history (OR = 2.70; AUC = 0.56). When the latter two factors and their multiplicative interactions with age-adjusted breast tissue aging (p = 0.01 and 0.02, respectively) were fitted, the AUC was 0.73 (95% CI 0.69–0.77), equivalent to a ninefold interquartile risk ratio. In summary, compared with using dense breasts alone, risk discrimination for interval breast cancers could be doubled by instead using breast density, BMI, family history and hormonal exposure. This would also give women with dense breasts, and their physicians, more information about the major consequence of having dense breasts—an increased risk of developing an interval breast cancer. 相似文献
80.
Chlamydia A in the female genital tract 总被引:14,自引:0,他引:14